FACTS ABOUT MBL77 REVEALED

mutations specified The point that, as explained beneath, CLL therapy is based to the presence or absence of such mutations. The present consensus is the fact, apart from clonal mutations, subclonal mutations with a variant allelic frequency starting from 5 to 10% (and thus under the threshold of detection by conventional molecular tactics) may be